• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滑膜肉瘤的预后因素及失败模式。

Synovial sarcoma prognostic factors and patterns of failure.

作者信息

Paulino Arnold C

机构信息

Department of Radiation Oncology, The University of Iowa College of Medicine, Iowa City, Iowa, USA.

出版信息

Am J Clin Oncol. 2004 Apr;27(2):122-7. doi: 10.1097/01.coc.0000047130.91699.dc.

DOI:10.1097/01.coc.0000047130.91699.dc
PMID:15057149
Abstract

From 1970 to 1999, 44 patients with synovial sarcoma were seen at the University of Iowa. Tumor size was > or = 5 cm in 24 (55%). Histologic classification was biphasic in 26 (59%) and monophasic in 18 (41%). Seven patients (16%) had distant metastasis at initial presentation. For the 37 nonmetastatic patients, local treatment consisted of wide local excision in 29 and amputation in 8; chemotherapy was administered to 10. For the 29 who underwent wide local excision, microscopic resection margins were negative in 18 and positive in 11; 19 received postoperative radiotherapy. The 5-, 10-, and 20-year overall survival rates for the nonmetastatic group were 65.6%, 45.5%, and 37.8%. On multivariate analysis using age as a continuous covariate, younger age (p = 0.028), biphasic histology (p = 0.014), and extremity sites treated with limb-sparing surgery (p = 0.001) were found to be predictors of a better overall survival. No local failures were found after 5 years from initial diagnosis. On multivariate analysis, tumor location at an extremity site was the only variable marginally found to have a better local control (p = 0.065). Of the 19 patients who developed distant metastasis, 5 (26%) failed >5 years and 2 (11%) failed >15 years of follow-up. Younger age, biphasic histology, and extremity sites were found to have a better survival outcome. Late distant relapses can occur with synovial sarcoma.

摘要

1970年至1999年期间,爱荷华大学共收治44例滑膜肉瘤患者。肿瘤大小≥5 cm者24例(55%)。组织学分类中,双相型26例(59%),单相型18例(41%)。7例患者(16%)初诊时即有远处转移。对于37例无转移患者,局部治疗包括29例行广泛局部切除,8例行截肢;10例接受化疗。在29例行广泛局部切除的患者中,显微镜下切除边缘阴性者18例,阳性者11例;19例接受术后放疗。无转移组的5年、10年和20年总生存率分别为65.6%、45.5%和37.8%。多因素分析将年龄作为连续协变量,结果显示年龄较小(p = 0.028)、双相组织学类型(p = 0.014)以及采用保肢手术治疗的四肢部位(p = 0.001)是总生存率较好的预测因素。自初始诊断后5年未发现局部复发。多因素分析显示,四肢部位的肿瘤位置是唯一在局部控制方面略有优势的变量(p = 0.

相似文献

1
Synovial sarcoma prognostic factors and patterns of failure.滑膜肉瘤的预后因素及失败模式。
Am J Clin Oncol. 2004 Apr;27(2):122-7. doi: 10.1097/01.coc.0000047130.91699.dc.
2
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.滑膜肉瘤:112例原发性肢体局限性肿瘤患者预后因素的多变量分析
J Clin Oncol. 2000 May;18(10):2087-94. doi: 10.1200/JCO.2000.18.10.2087.
3
The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.经典的预后因素肿瘤分期、肿瘤大小和肿瘤分级是滑膜肉瘤预后最强的预测指标:SSX融合类型或埃兹蛋白表达无作用。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):189-95. doi: 10.1097/PAI.0b013e31818a6f5c.
4
Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.影响局限性滑膜肉瘤的预后因素:一项针对51例患者的单机构回顾性研究。
Med Oncol. 2014 Jun;31(6):958. doi: 10.1007/s12032-014-0958-8. Epub 2014 Apr 26.
5
Synovial sarcoma: the importance of size and location for survival.滑膜肉瘤:大小和位置对生存的重要性
Clin Orthop Relat Res. 2004 Feb(419):155-61.
6
Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival.滑膜肉瘤:肿瘤大小、切除边缘及有丝分裂活性对生存的预后意义
J Clin Oncol. 1996 Apr;14(4):1201-8. doi: 10.1200/JCO.1996.14.4.1201.
7
Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.儿童和青少年滑膜肉瘤:预后因素和生存结果的多因素分析。
Ann Surg Oncol. 2013 Jan;20(1):73-9. doi: 10.1245/s10434-012-2587-9. Epub 2012 Aug 10.
8
Synovial sarcoma in children: surgical lessons from a single institution and review of the literature.儿童滑膜肉瘤:来自单一机构的手术经验及文献综述
J Am Coll Surg. 2001 Mar;192(3):305-13. doi: 10.1016/s1072-7515(00)00806-1.
9
Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.儿童和青年非横纹肌肉瘤软组织肉瘤的辅助放疗。
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):150-7. doi: 10.1016/j.ijrobp.2010.05.005. Epub 2011 May 6.
10
Synovial sarcoma involving skull base--a retrospective analysis of diagnosis and treatment of 21 cases in one institution.累及颅底的滑膜肉瘤——单中心 21 例回顾性分析诊断与治疗。
Oral Oncol. 2011 Jul;47(7):671-6. doi: 10.1016/j.oraloncology.2011.04.014. Epub 2011 Jun 8.

引用本文的文献

1
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.肉瘤微环境中的细胞状态和生态系统与预后相关,并可预测对免疫治疗的反应。
Nat Cancer. 2024 Apr;5(4):642-658. doi: 10.1038/s43018-024-00743-y. Epub 2024 Mar 1.
2
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.表柔比星、顺铂联合异环磷酰胺与标准化疗方案治疗晚期/不可切除的原发性胸部肉瘤的对比
J Cancer Res Clin Oncol. 2023 Aug;149(9):5479-5491. doi: 10.1007/s00432-022-04454-8. Epub 2022 Dec 4.
3
Multimodal Risk-Adapted Treatment in Surgical Patients With Synovial Sarcoma: A Preoperative Nomogram-Guided Adjuvant Treatment Strategy.
滑膜肉瘤手术患者的多模式风险适应性治疗:一种术前列线图引导的辅助治疗策略。
Front Surg. 2020 Dec 21;7:579726. doi: 10.3389/fsurg.2020.579726. eCollection 2020.
4
Synovial sarcoma mimicking a traumatic pseudoaneurysm in the upper extremity.上肢滑膜肉瘤酷似创伤性假性动脉瘤。
BMJ Case Rep. 2019 Nov 26;12(11):e232135. doi: 10.1136/bcr-2019-232135.
5
Synovial Sarcoma: A Clinicopathological and Radiological Study of 12 Cases Seen Over 18 Years.滑膜肉瘤:18年间12例病例的临床病理及影像学研究
World J Oncol. 2010 Feb;1(1):14-18. doi: 10.4021/wjon2009.12.1201. Epub 2010 Feb 1.
6
Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.滑膜肉瘤中增强子的外显子 2(EZH2)表达作为预后的一个有前途的指标。
Bosn J Basic Med Sci. 2017 Nov 20;17(4):302-308. doi: 10.17305/bjbms.2017.1938.
7
Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.新辅助化疗对滑膜肉瘤患者预后的影响。
World J Surg Oncol. 2017 May 11;15(1):101. doi: 10.1186/s12957-017-1165-9.
8
Synovial Sarcoma of the Abdominal Wall.腹壁滑膜肉瘤
Radiol Case Rep. 2015 Dec 7;2(4):108. doi: 10.2484/rcr.v2i4.108. eCollection 2007.
9
The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma.(18)F-FDG PET/CT作为滑膜肉瘤患者预后因素的作用
Nucl Med Mol Imaging. 2015 Mar;49(1):33-41. doi: 10.1007/s13139-014-0301-5. Epub 2014 Oct 30.
10
Synovial sarcoma presenting as an avascular mass: radiologic-pathologic correlation.表现为无血管肿块的滑膜肉瘤:影像学与病理对照
Skeletal Radiol. 2015 Feb;44(2):279-84. doi: 10.1007/s00256-014-1964-9. Epub 2014 Aug 1.